Page 1

Press Release Materialise Reports Third Quarter 2021 Results << LEUVEN , Belgium -- ( BUSINESS WIRE ) -- Oct . 28 , 2021-- Materialise NV ( NASDAQ : MTLS ) , a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services , today announced its financial results for the third quarter ended September 30 , 2021 . Highlights - Third Quarter 2021 Total revenue increased 28 % to 52,195 KEUR for the third quarter of 2021 from 40,785 KEUR for the 2020 period . Total deferred revenues from annual software sales and maintenance fees increased 547 KEUR to 30,789 KEUR compared to December 31 , 2020 . Adjusted EBITDA increased 62 % to 9,739 KEUR for the third quarter of 2021 from to 6,023 KEUR for the 2020 period . Net profit for the third quarter of 2021 was 8,652 KEUR , or 0.15 EUR per diluted share , compared to a loss of ( 282 ) KEUR , or ( 0.01 ) EUR per diluted share , for the 2020 period . Total cash was 194,946 KEUR at the end of the quarter . Executive Chairman Peter Leys commented , " While the COVID - 19 pandemic lingers on in certain parts of the world , our record third quarter results show that Materialise is coming out of this crisis stronger than before : our revenue grew by 28 % to a quarterly record of 52.2 KEUR and solid operational performances in all three of our segments resulted in a quarterly Adjusted EBITDA record of 9.7 million EUR . We plan to continue to invest to further accelerate our growth and look forward to introducing new product upgrades at next month's Formnext in Frankfurt . " Third Quarter 2021 Results Total revenue for the third quarter of 2021 increased 28.0 % to 52,195 kEUR from 40,785 KEUR for the third quarter of 2020. Adjusted EBITDA increased 62 % to 9,739 KEUR from 6,023 KEUR in the previous period . The Adjusted EBITDA margin ( Adjusted EBITDA divided by total revenue ) for the third quarter of 2021 increased to 18.7 % from 14.8 % for the third quarter of 2020 . Revenue from our Materialise Software segment increased 10.4 % to 10,468 KEUR for the third quarter of 2021 from 9,478 KEUR for the same quarter last year . Segment EBITDA increased 19.1 % to 3,708 KEUR from 3,114 KEUR while the segment EBITDA margin increased to 35.4 % compared to 32.9 % in the prior - year period . Revenue from our Materialise Medical segment increased 10.2 % to 18,910 kEUR for the third quarter of 2021 compared to 17,161 KEUR for the same period in 2020. Segment EBITDA decreased to 5,251 KEUR from 5,476 KEUR while the segment EBITDA margin was 27.8 % compared to 31.9 % for the third quarter of 2020 .